179 related articles for article (PubMed ID: 23015305)
1. Overexpression of galectin-3 enhances migration of colon cancer cells related to activation of the K-Ras-Raf-Erk1/2 pathway.
Wu KL; Huang EY; Jhu EW; Huang YH; Su WH; Chuang PC; Yang KD
J Gastroenterol; 2013 Mar; 48(3):350-9. PubMed ID: 23015305
[TBL] [Abstract][Full Text] [Related]
2. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor.
Nagy N; Bronckart Y; Camby I; Legendre H; Lahm H; Kaltner H; Hadari Y; Van Ham P; Yeaton P; Pector JC; Zick Y; Salmon I; Danguy A; Kiss R; Gabius HJ
Gut; 2002 Mar; 50(3):392-401. PubMed ID: 11839721
[TBL] [Abstract][Full Text] [Related]
3. FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway.
Li K; Guo Q; Yang J; Chen H; Hu K; Zhao J; Zheng S; Pang X; Zhou S; Dang Y; Li L
Oncotarget; 2017 Jan; 8(3):5048-5056. PubMed ID: 27926503
[TBL] [Abstract][Full Text] [Related]
4. HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.
Zhang X; Liu G; Ding L; Jiang T; Shao S; Gao Y; Lu Y
J Cell Biochem; 2018 Mar; 119(3):2864-2874. PubMed ID: 29073728
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis.
Basu Roy UK; Henkhaus RS; Loupakis F; Cremolini C; Gerner EW; Ignatenko NA
Int J Cancer; 2013 Jul; 133(1):43-57. PubMed ID: 23280667
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Ras/Raf/ERK1/2 Signaling Pathway Restores Cultured Spinal Cord-Injured Neuronal Migration, Adhesion, and Dendritic Spine Development.
Xu D; Cao F; Sun S; Liu T; Feng S
Neurochem Res; 2016 Aug; 41(8):2086-96. PubMed ID: 27097549
[TBL] [Abstract][Full Text] [Related]
7. MiR-21/RASA1 axis affects malignancy of colon cancer cells via RAS pathways.
Gong B; Liu WW; Nie WJ; Li DF; Xie ZJ; Liu C; Liu YH; Mei P; Li ZJ
World J Gastroenterol; 2015 Feb; 21(5):1488-97. PubMed ID: 25663768
[TBL] [Abstract][Full Text] [Related]
8. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ
Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335
[TBL] [Abstract][Full Text] [Related]
9. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
10. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.
Rajalingam K; Wunder C; Brinkmann V; Churin Y; Hekman M; Sievers C; Rapp UR; Rudel T
Nat Cell Biol; 2005 Aug; 7(8):837-43. PubMed ID: 16041367
[TBL] [Abstract][Full Text] [Related]
11. ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics.
Levidou G; Saetta AA; Gigelou F; Karlou M; Papanastasiou P; Stamatelli A; Kavantzas N; Michalopoulos NV; Agrogiannis G; Patsouris E; Korkolopoulou P
World J Surg Oncol; 2012 Feb; 10():47. PubMed ID: 22376079
[TBL] [Abstract][Full Text] [Related]
12. Dimerization of the kinase ARAF promotes MAPK pathway activation and cell migration.
Mooz J; Oberoi-Khanuja TK; Harms GS; Wang W; Jaiswal BS; Seshagiri S; Tikkanen R; Rajalingam K
Sci Signal; 2014 Aug; 7(337):ra73. PubMed ID: 25097033
[TBL] [Abstract][Full Text] [Related]
13. RSK activation via ERK modulates human colon cancer cells response to PTHrP.
Calvo N; Carriere P; Martin MJ; Gentili C
J Mol Endocrinol; 2017 Jul; 59(1):13-27. PubMed ID: 28385776
[TBL] [Abstract][Full Text] [Related]
14. Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells.
Henkhaus RS; Gerner EW; Ignatenko NA
Biol Chem; 2008 Jun; 389(6):757-64. PubMed ID: 18627290
[TBL] [Abstract][Full Text] [Related]
15. Radiation-induced increase in cell migration and metastatic potential of cervical cancer cells operates via the K-Ras pathway.
Su WH; Chuang PC; Huang EY; Yang KD
Am J Pathol; 2012 Feb; 180(2):862-71. PubMed ID: 22138581
[TBL] [Abstract][Full Text] [Related]
16. Extracellular galectin-3 facilitates colon cancer cell migration and is related to the epidermal growth factor receptor.
Wu KL; Kuo CM; Huang EY; Pan HM; Huang CC; Chen YF; Hsiao CC; Yang KD
Am J Transl Res; 2018; 10(8):2402-2412. PubMed ID: 30210679
[TBL] [Abstract][Full Text] [Related]
17. A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells.
Huang EY; Chen YF; Chen YM; Lin IH; Wang CC; Su WH; Chuang PC; Yang KD
Cell Death Dis; 2012 Jan; 3(1):e251. PubMed ID: 22237208
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-30a suppresses tumor progression by blocking Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma.
Zhou K; Luo X; Wang Y; Cao D; Sun G
Biomed Pharmacother; 2017 Sep; 93():1025-1032. PubMed ID: 28732393
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 mediates cross-talk between K-Ras and Let-7c tumor suppressor microRNA.
Levy R; Biran A; Poirier F; Raz A; Kloog Y
PLoS One; 2011; 6(11):e27490. PubMed ID: 22102901
[TBL] [Abstract][Full Text] [Related]
20. Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.
Steelman LS; Franklin RA; Abrams SL; Chappell W; Kempf CR; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo P; Ruvolo V; Evangelisti C; Martelli AM; McCubrey JA
Leukemia; 2011 Jul; 25(7):1080-94. PubMed ID: 21494257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
